BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31484596)

  • 1. A selective sphingomyelin synthase 2 inhibitor ameliorates diet induced insulin resistance
    Huang Y; Huang T; Zhen X; Li Y; Mo M; Ye D; Cheng N
    Pharmazie; 2019 Sep; 74(9):553-558. PubMed ID: 31484596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
    Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
    Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.
    Li Y; Huang T; Lou B; Ye D; Qi X; Li X; Hu S; Ding T; Chen Y; Cao Y; Mo M; Dong J; Wei M; Chu Y; Li H; Jiang XC; Cheng N; Zhou L
    Eur J Med Chem; 2019 Feb; 163():864-882. PubMed ID: 30580239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
    Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
    World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors.
    Adachi R; Ogawa K; Matsumoto SI; Satou T; Tanaka Y; Sakamoto J; Nakahata T; Okamoto R; Kamaura M; Kawamoto T
    Eur J Med Chem; 2017 Aug; 136():283-293. PubMed ID: 28505533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of rutin on liver injury in type 2 diabetic db/db mice.
    Liang W; Zhang D; Kang J; Meng X; Yang J; Yang L; Xue N; Gao Q; Han S; Gou X
    Biomed Pharmacother; 2018 Nov; 107():721-728. PubMed ID: 30138894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes.
    Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y
    J Biol Chem; 2011 Aug; 286(32):28544-55. PubMed ID: 21669879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleen-kidney supplementing formula alleviates insulin resistance via regulating AKT/glycogen synthase kinase 3β pathway in rats with type 2 diabetic induced by high-fat diet.
    Tian C; Wang Y; La X; Li J; Zhang B
    J Tradit Chin Med; 2019 Apr; 39(2):199-206. PubMed ID: 32186042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
    Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of the selective sphingomyelin synthase 2 inhibitors with the novel structure of oxazolopyridine.
    Qi XY; Cao Y; Li YL; Mo MG; Zhou L; Ye DY
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3511-3515. PubMed ID: 28619536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells.
    Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D
    Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Krüppel-like factor 14 increases insulin sensitivity through activation of PI3K/Akt signal pathway.
    Yang M; Ren Y; Lin Z; Tang C; Jia Y; Lai Y; Zhou T; Wu S; Liu H; Yang G; Li L
    Cell Signal; 2015 Nov; 27(11):2201-8. PubMed ID: 26226221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing plasma membrane sphingomyelin increases insulin sensitivity.
    Li Z; Zhang H; Liu J; Liang CP; Li Y; Li Y; Teitelman G; Beyer T; Bui HH; Peake DA; Zhang Y; Sanders PE; Kuo MS; Park TS; Cao G; Jiang XC
    Mol Cell Biol; 2011 Oct; 31(20):4205-18. PubMed ID: 21844222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casein glycomacropeptide-derived peptide IPPKKNQDKTE ameliorates high glucose-induced insulin resistance in HepG2 cells via activation of AMPK signaling.
    Song JJ; Wang Q; Du M; Li TG; Chen B; Mao XY
    Mol Nutr Food Res; 2017 Feb; 61(2):. PubMed ID: 27506476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalin attenuates high fat diet-induced insulin resistance and ectopic fat storage in skeletal muscle, through modulating the protein kinase B/Glycogen synthase kinase 3 beta pathway.
    Xi YL; Li HX; Chen C; Liu YQ; Lv HM; Dong SQ; Luo EF; Gu MB; Liu H
    Chin J Nat Med; 2016 Jan; 14(1):48-55. PubMed ID: 26850346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.
    Park M; Kaddai V; Ching J; Fridianto KT; Sieli RJ; Sugii S; Summers SA
    J Biol Chem; 2016 Nov; 291(46):23978-23988. PubMed ID: 27703011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway.
    Zheng X; Zhao MG; Jiang CH; Sheng XP; Yang HM; Liu Y; Yao XM; Zhang J; Yin ZQ
    Phytomedicine; 2020 Jan; 66():153130. PubMed ID: 31790897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis.
    Ding T; Li Z; Hailemariam T; Mukherjee S; Maxfield FR; Wu MP; Jiang XC
    J Lipid Res; 2008 Feb; 49(2):376-85. PubMed ID: 17982138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice.
    Sugimoto M; Shimizu Y; Zhao S; Ukon N; Nishijima K; Wakabayashi M; Yoshioka T; Higashino K; Numata Y; Okuda T; Tamaki N; Hanamatsu H; Igarashi Y; Kuge Y
    Biochim Biophys Acta; 2016 Aug; 1861(8 Pt A):688-702. PubMed ID: 27151272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 4-Benzyloxybenzo[ d]isoxazole-3-amine Derivatives as Highly Selective and Orally Efficacious Human Sphingomyelin Synthase 2 Inhibitors that Reduce Chronic Inflammation in db/ db Mice.
    Mo M; Yang J; Jiang XC; Cao Y; Fei J; Chen Y; Qi X; Chu Y; Zhou L; Ye D
    J Med Chem; 2018 Sep; 61(18):8241-8254. PubMed ID: 30074791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.